# Impact of DApagliflozin on Cardiac Function Following Anterior Myocardial Infarction in Non-Diabetic Patients

Study · id `cardio:ct-nct05424315` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05424315](<https://clinicaltrials.gov/study/NCT05424315>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05424315

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Heart failure; Acute care and long-term living  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT05424315. Randomized; quadruple masking; primary purpose prevention. Start 2021-10-01 (actual); primary completion 2022-04-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 2/3
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT05424315, source copy `cardio:ctgov-nct05424315-2024-11-19`, retrieved 2026-10-26)
- Started: 2021-10-01 (actual) (ClinicalTrials.gov record NCT05424315, source copy `cardio:ctgov-nct05424315-2024-11-19`, retrieved 2026-10-26)
- Primary completion: 2022-04-30 (actual) (ClinicalTrials.gov record NCT05424315, source copy `cardio:ctgov-nct05424315-2024-11-19`, retrieved 2026-10-26)
- Completion: 2022-04-30 (actual) (ClinicalTrials.gov record NCT05424315, source copy `cardio:ctgov-nct05424315-2024-11-19`, retrieved 2026-10-26)
- Countries: Egypt (ClinicalTrials.gov record NCT05424315, source copy `cardio:ctgov-nct05424315-2024-11-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05424315-2024-11-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Impact of DApagliflozin on Cardiac Function Following Anterior Myocardial Infarction in Non-Diabetic Patients
- Acronym: DACAMI
- Condition: Anterior MI
- Intervention (Drug): Dapagliflozin 10mg
- Intervention (Drug): Glucose Tab
- Lead sponsor: Omar Younis
- Lead sponsor class: OTHER\_GOV
- Collaborator: Ain Shams University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as a collaborator: Ain Shams University (`cardio:org-ain-shams-university`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of dapagliflozin on cardiac function following anterior myocardial infarction in non-diabetic patients - DACAMI (a randomized controlled clinical trial) (`cardio:pubmed-36889650`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 9242e3936902a22b72e4dd54942341f643bb683e151c2f9a74b7e75eb7cff320
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
